Bladder Cancer Advocacy Network (BCAN)

Viewing 1-14 of 14 articles

BCAN 2019: Genomics in Bladder Cancer

BCAN 2019: Integrated Mutation Profiling of Actionable Cancer Targets (IMPACT)

BCAN 2019: The Biomarker Discovery Process for Bladder Cancer

BCAN 2019: FDA Collaboration with the Bladder Cancer Community

BCAN 2019: Proteogenomic Characterization of Muscle-invasive Bladder Cancer

BCAN 2019: Race and Guideline Based Treatment in Bladder Cancer

BCAN 2019: FDA Approval of Therapies in the Context of BCG Shortages and Alternative Therapies

BCAN 2019: Diagnostic Approach in Clinically Node Positive Bladder Cancer

BCAN 2019: FDA Collaboration in Adjuvant Trials in Muscle Invasive Bladder Cancer

BCAN 2019: Palliative Care Use Amongst Patients With Bladder Cancer

BCAN 2019: Radiographic Consideration Prior to Clinical Trial Enrollment

BCAN 2019: The Introduction of Palliative Care in Bladder Cancer

BCAN 2019: How Urology Can Improve Implementation and Dissemination of Palliative Care in Bladder Cancer

Collaborating to Move Research Forward - 2019 BCAN Think Tank